RafaelVillicanaMD
Nephrology • Loma Linda, CAAssociate Professor, Medicine, Loma Linda University Medical Center
Dr. Villicana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
25865 Barton Rd
Ste 101
Loma Linda, CA 92354Phone+1 909-558-3636Fax+1 909-558-3722
Education & Training
University of California (San Francisco)Fellowship, Nephrology, 2003 - 2005
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2000 - 2003
Michigan State University College of Human MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2003 - 2025
MN State Medical License 2001 - 2004- American Board of Internal Medicine Nephrology
Clinical Trials
- C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- 5 citationsEfficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analy...Arman Faravardeh, Sanjeev Akkina, Rafael Villicana, Giselle Guerra, Misbah A. Moten
Annals of Transplantation. 2021-04-16 - 14 citationsAnalysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein-Barr Virus (EBV) Assessments-A Single Tertiary Referral Center Experience and Rev...Eric Lau, Justin T. Moyers, Billy C Wang, Il Seok Daniel Jeong, Joanne Lee
Cancers. 2021-02-21 - 11 citationsShould donors who have used marijuana be considered candidates for living kidney donationDavid Ruckle, Mohamed Keheila, Benjamin West, Pedro Baron, Rafael Villicana
Clinical Kidney Journal. 2019-06-01
Journal Articles
- Transplantation of Hepatitis C Virus (HCV) Antibody Positive, Nucleic Acid Test Negative Donor Kidneys to HCV Negative Patients Frequently Results in Seroconversion bu...Philip Wai, Jill Weissman, Thanh Hoang, Pedro Baron, Arputharaj Kore, Rafael Villicana, American journal of transplantation
Press Mentions
RSN’s 29th Annual Virtual Patient Education & Lifestyle MeetingOctober 7th, 2022- Rafael Villicana, MDJanuary 28th, 2022
I Am on Anti-Rejection Medication, Is It Safe to Be Around My Pets?October 31st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
